Approved & therapeutic
Selank
Synthetic Tuftsin Analog
A synthetic peptide derived from tuftsin (a naturally occurring immune peptide) developed in Russia. Studied for its anti-anxiety and cognitive-enhancing properties.
Also known as: TP-7
- Status
- Selank is approved in at least one country outside the U.S. but not approved by the FDA.
- Evidence
- Early human data. Only small or early-phase studies in people so far.
- Half-life
- ~2-3 minutes (effects persist much longer)
- How it's taken
- Intranasal spray
- Mechanism
- Cognitive / mood
- Pathways
- Neurotrophic
How Selank works
Modulates the expression of brain-derived neurotrophic factor (BDNF) and influences serotonin and dopamine metabolism. Also enhances immune function through its tuftsin-like activity.
What research has looked at
- Reduced anxiety without sedation
- Improved focus and mental clarity
- Enhanced memory formation
- Immune system support
- No addictive potential shown
Evidence level: Early human data. Only small or early-phase studies in people so far. These are areas studied or reported, not promised effects.
Reported side effects and risks
- Mild nasal irritation (intranasal use)
- Fatigue in some users
- Headache
- Limited Western clinical data
- Not FDA-approved
Sources
- PubMed research on selank anxiolytic tuftsin analog · NIH · National Library of Medicine
- DrugBank record for selank · DrugBank
- StatPearls / NCBI Bookshelf on selank · NCBI Bookshelf
Track Selank in Peptide Vault
Log every dose, set reminders on your own schedule, rotate injection sites and keep your vials organized. Peptide Vault records what you enter. It doesn't recommend compounds or doses. iPhone, on-device.
Related compounds
Selank FAQ
What is Selank?
A synthetic peptide derived from tuftsin (a naturally occurring immune peptide) developed in Russia. Studied for its anti-anxiety and cognitive-enhancing properties.
How does Selank work?
Modulates the expression of brain-derived neurotrophic factor (BDNF) and influences serotonin and dopamine metabolism. Also enhances immune function through its tuftsin-like activity.
Is Selank FDA approved?
No. Selank is approved in at least one country outside the U.S. but not approved by the FDA. Evidence level: early human data. Only small or early-phase studies in people so far.
What is the half-life of Selank?
Reported half-life: ~2-3 minutes (effects persist much longer).
How is Selank taken?
Intranasal spray.
What side effects have been reported with Selank?
Reported in the sources: Mild nasal irritation (intranasal use); Fatigue in some users; Headache; Limited Western clinical data; Not FDA-approved.
Educational summary compiled from the sources listed above. Not medical advice. Peptide Vault does not sell, source or recommend any compound. Talk to a qualified clinician before starting or changing anything.